Skip to main content

Table 4 Performance of the classification tree in the training and testing sets

From: Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approach

Sets

Groups

Sensitivity

Specificity

Training set

33cases/33 controls

100% (33/33)

93.94% (31/33)

Testing set

48cases/33 controls

100% (48/48)

96.97% (32/33)